E3 ubiquitin ligases as novel targets for inflammatory diseases

dc.contributor.authorGaikwad, Anil Bhanudas
dc.date.accessioned2023-12-20T09:33:01Z
dc.date.available2023-12-20T09:33:01Z
dc.date.issued2016-04
dc.description.abstractUbiquitination is one of the post translational modifications which decide the fate of various proteins in the cells, by either directing them towards proteasomal degradation or participation in several cell signalling pathways. Recently, the role of ubiquitination has been unravelled in pathogenesis and progression of various diseases, where inflammation is critical, like obesity, insulin resistance, atherosclerosis, angiotensin-II induced cardiac inflammation and asthma. E3 ligases are known to be instrumental in regulation of the inflammatory cascade. This review focuses on the role of different E3 ligases in the development of inflammatory diseases and thus may help us to target these E3 ligases in future drug discovery to prevent inflammation.en_US
dc.identifier.urihttps://www.sciencedirect.com/science/article/abs/pii/S1043661816300184
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13463
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectPharmacyen_US
dc.subjectAtherosclerosisen_US
dc.subjectDrugen_US
dc.titleE3 ubiquitin ligases as novel targets for inflammatory diseasesen_US
dc.typeArticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: